Hepagard (100+150) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Synmedic Laboratories. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are L-ornithine-L-Aspartate, Pancreatin. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 78.5 (arround $1.099 US Dollar)
Generic (Salt) Combination :
(L-ornithine-L-Aspartate+ Pancreatin)
Pharma Company :
Synmedic Laboratories
Brand Label :
Hepagard (100+150)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
L-ornithine-L-Aspartate-150 mg
Pancreatin-100 mg
Pack Size/Qty/Vol :
10 Tablet
Price Unit :
Rs 7.85 INR (arround $0.1099 US Dollar)
Price Pack :
Rs 78.5 INR (arround $1.099 US Dollar)
Drug details for Hepagard (100+150)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Hepagard (100+150) are :
L-ornithine-L-Aspartate-150 mg
Pancreatin-100 mg
L-ornithine-L-Aspartate Indication (Prescribed for or used as):
For more details on L-ornithine-L-Aspartate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : L-ornithine-L-Aspartate..
Pancreatin Indication (Prescribed for or used as): Chronic pancreatitis and other exocrine pancreatic deficiency states.
For more details on Pancreatin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Pancreatin..
Hepagard (100+150) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 10 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Hepagard (100+150), which have same Fixed-Dose Combination of active substances or ingredients (i.e. L-ornithine-L-Aspartate-150 mg Pancreatin-100 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.